Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133676) titled 'A prospective, multicenter clinical trial evaluating the safety and efficacy of an implantable left ventricular assist system for the treatment of end-stage heart failure' on Sept. 30.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Chinese Academy of Medical Sciences Peking Union Medical College TEDA International Cardiovascular Hospital
Condition:
Advanced refractory left heart failure
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-22
Target Sample Size: Experimental group:50;
Countries of Recruitment:
China
To know more, visit https://www.ch...